Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-036822
Filing Date
2015-05-11
Accepted
2015-05-11 16:12:27
Documents
13
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-7301_110q.htm 10-Q 600129
2 EX-10.2 a15-7301_1ex10d2.htm EX-10.2 378367
3 EX-10.3 a15-7301_1ex10d3.htm EX-10.3 198636
4 EX-31.1 a15-7301_1ex31d1.htm EX-31.1 10932
5 EX-31.2 a15-7301_1ex31d2.htm EX-31.2 9937
6 EX-32.1 a15-7301_1ex32d1.htm EX-32.1 5814
7 EX-32.2 a15-7301_1ex32d2.htm EX-32.2 4726
  Complete submission text file 0001104659-15-036822.txt   5050586

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ovas-20150331.xml EX-101.INS 697059
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovas-20150331.xsd EX-101.SCH 26264
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovas-20150331_cal.xml EX-101.CAL 33873
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovas-20150331_def.xml EX-101.DEF 109970
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ovas-20150331_lab.xml EX-101.LAB 288192
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovas-20150331_pre.xml EX-101.PRE 213709
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 15850854
SIC: 2834 Pharmaceutical Preparations